Solutions / Insurance Access
Insurance Built for the Peptide Channel, Not Adapted to It.
The World Insurance Network peptide program, engineered around how peptide practices actually operate and around the modalities standard carriers routinely decline. Helios members get access to it.
Watch
Insurance for the Peptide Channel, Explained
Why standard policies stop short of peptide activity, and how this program is built to respond.
The program serves peptide distributors, wholesalers, and medical practices that supply peptides labeled for professional use only and counsel patients on their use. Coverage is placed through World Insurance Network, a licensed insurance producer. Availability, eligibility, terms, limitations, and exclusions are determined by underwriting.
Helios Consultants is not an insurance producer and does not sell, solicit, or negotiate insurance.
Will my malpractice policy cover peptide therapy?
Often it will not. Advanced modalities are frequently excluded or declined outright by standard carriers, and most clinicians discover this only when a claim is filed against them.
The pathway to professional-use peptides is deliberately narrow, and general-market policies were not written with that pathway in mind. Reading your existing policy against the modalities you actually offer is the first step, and it is worth doing whether or not you work with us.
Two exposures, two programs
Peptide activity splits into two separate exposures. They have different triggers, they transfer separately, and most practices carry both without knowing it.
Product liability
Responds when the product itself causes bodily injury. It follows the product through the chain, which puts manufacturers, distributors, wholesalers, and practices that buy wholesale and bill retail in the same claim pipeline.
Professional liability
Responds when the advice causes harm. The trigger is bodily injury arising from a negligent recommendation, not from the product. It is structured to sit alongside your existing malpractice policy without disturbing it.
A standard policy usually answers neither.
What happens if you're not covered
Nobody in this space is asking clinicians to read their policy. The conversation is about revenue, protocols, and supply. It is never about what your carrier will actually respond to when a complaint arrives.
That silence is the exposure.
An exclusion does not announce itself. It sits in the schedule until a claim is filed, and then it decides who pays. If peptide therapy is excluded from your current policy, the defense, the settlement, and every hour you spend on it are yours.
You have already invested in the education of your staff and physicians, the securing of supply, and the marketing of your practice. The question is whether any of it is protected.
Why standard policies do not follow peptide activity
Four things catch practices out.
Marking product up makes you a distributor
A clinic that buys wholesale and bills retail is, for insurance purposes, acting as a distributor. That places the practice in the product claim pipeline alongside the manufacturer, a position most clinics do not know they occupy, and one a malpractice policy was never written to cover.
Malpractice and product liability answer different questions
A malpractice policy responds to bodily injury from negligent care or advice. It does not respond to the product. When a product claim is made, carriers subrogate against the manufacturer, which is why the practice's own position in the chain matters.
Your supply agreements may already commit you
Indemnification language in purchase agreements is rarely peptide specific. Practices sign it, assume an existing policy answers it, and can end up in breach of their own contract without knowing.
The channel has to have a physician in it
Carriers will write this risk when a licensed physician sits in the chain and the product is labeled for professional use only. Consumer direct peptide sales are not insurable on this basis.
Built around the channel, not adapted to it
The pathway to professional-use peptides is deliberately narrow. Eligibility runs through medical practices operating under a medical director with an NPI number, sourcing from reputable manufacturers and distributors rather than the open market.
This program was engineered around that very channel and insures it as it truly operates, rather than adapting a general-market form to a risk it was never written for.
That sourcing discipline is not incidental to the coverage. It is what makes the channel assessable, and it is why the program sits alongside Pharmaceutical Supply and Compliance Solutions rather than as a separate purchase.
Who can be written
Eligibility turns on how the product is labeled and who sits in the chain, not on which peptide is involved.
- Product labeled for professional use only
- A licensed physician in the chain
- An NPI for the practice or practitioner
- Sourcing through reputable manufacturers and distributors
- Adherence to the program's training, documentation, and recordkeeping standards
- Consumer direct peptide sales cannot be written
Availability, eligibility, terms, limitations, and exclusions are determined by underwriting.
What the program covers
Each part answers a different piece of the exposure. Most practices need more than one. Which of them apply to your practice is worked through on the coverage review call.
- Peptide product liabilityFor the product itself, wherever the practice sits in the supply chain.
- Peptide professional liabilityFor bodily injury arising from negligent recommendation or protocol advice.
- Clinic insuranceFor practices incorporating peptides into patient care.
- Med spa peptide insuranceFor med spas adding peptide services to an existing treatment menu.
- Medical director liabilityFor the physician whose name sits behind the protocol.
- Distributor and supply side coverageFor wholesalers and suppliers in the professional use channel.
- White label product liabilityFor practices putting their own brand on product.
- Coverage gap reviewA read of what your current policies respond to, and where they stop.
The products liability form is written without exclusions by peptide type, so cover applies across the peptide portfolio rather than splitting it into covered and uncovered products. Terms, limitations, and exclusions are set by the issued policy. The form and the current schedule are walked through with you on the call, before anything is bound.
How it works
- Book a coverage review and go through your current policies against the modalities you actually offer
- Confirm eligibility against professional use only labeling, a licensed physician in the chain, and an active NPI
- Introduction to the producer, who handles the quote, the terms, and the binding
- Structure coverage to complement, not replace, your existing malpractice policy
- Maintain eligibility through the program's training, documentation, and recordkeeping standards
Who places the coverage
Coverage is placed through World Insurance Network, a licensed insurance producer firm.
Helios Consultants is not an insurance producer and does not sell, solicit, or negotiate insurance, and does not underwrite, bind, or issue policies. Our role is the documentation, training, and recordkeeping standards that make these modalities assessable to an underwriter.
There is no direct application route. Every introduction to the producer is made on a Helios coverage review call, where your existing coverage, modalities, and states are gone through first. The form, the schedule, and the quote all follow from that call.
Book a Coverage ReviewThe natural counterpart to the rest of the program
Carriers exclude what they cannot assess. Peptide therapy is not declined because it is uninsurable. It is declined because most practices cannot show an underwriter a documented supply chain, a training record, and consistent charting.
This program stands as the natural counterpart to the Helios philosophy of peptide protocol education, practice build-out revenue models, and access to supply. Each pillar produces the evidence the next one depends on, and coverage is where that evidence pays out.
Frequently asked questions
Advanced modalities without established documentation standards are difficult to underwrite. Carriers exclude what they cannot assess. A documented supply chain and consistent recordkeeping change that assessment.
No. It is structured to sit alongside your existing medical malpractice cover without disturbing it. Keeping peptide exposure in its own program is also what keeps a conventional malpractice history clean.
Usually not. A malpractice policy responds to bodily injury arising from negligent care or advice. When a practice buys product wholesale and bills it retail, that practice is acting as a distributor, and the product itself sits outside what a malpractice policy was written to cover. Those are two different exposures and they transfer separately.
The products liability form is written without exclusions by peptide type, so cover applies across the peptide portfolio rather than splitting it into covered and uncovered products, subject to the terms of the issued policy. The form and the current schedule are walked through with you on the coverage review call.
Yes. The professional liability component responds to bodily injury arising from negligent recommendation or protocol advice, including the guidance you deliver on peptide protocols and treatment plans.
Professional use only labeling, a licensed physician in the chain, an NPI for the practice or practitioner, sourcing through reputable manufacturers and distributors, and adherence to the program's documentation, training, and recordkeeping requirements. Availability, terms, limitations, and exclusions are subject to underwriting.
Not under this program. Carriers require professional use only labeling and a licensed physician in the chain. Consumer direct sales fall outside that structure.
Ask your carrier or broker for the current schedule of exclusions and read it against the modalities you actually offer. The coverage review that begins every Helios consultation does exactly this, and it is worth doing whether or not you work with us.
World Insurance Network, a licensed insurance producer firm. Helios Consultants is not an insurance producer and does not sell, solicit, or negotiate insurance.
On a call. Book a coverage review, where your current coverage, modalities, and states are gone through first. The introduction to the producer, the form, the schedule, and the quote all follow from that call. Quotes, terms, and binding are handled by the producer, not by Helios.
ImportantInsurance availability, eligibility, and coverage are subject to underwriting, applicable policy terms, limitations, and exclusions. Coverage is placed through World Insurance Network, a licensed insurance producer. Helios Consultants LLC is not an insurance producer. Program materials do not constitute legal, medical, insurance, or regulatory advice. Clinics should consult their own qualified professional advisers.
An investment of that magnitude warrants protection of equal caliber.
You have already committed the education of your staff and physicians, the securing of supply, the marketing of your practice, and the disciplined application of Helios revenue generation principles. What stands behind it is not merely capital, but the far rarer currency of time. Start with a coverage review.